S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
3 Grocery Store Stocks to Put in Your Cart
Greyscale Bitcoin Trust (OTCMKTS: GBTC) Stock is the Bitcoin Derivative of Choice
Opendoor Technologies (NASDAQ: OPEN) Stock is a Disruptive Housing Play
The Latest: Some Polish hospitals suspend vaccination
pixel
Carmaker Stellantis shares jump in Milan, Paris on first day
Alberta leader urges Biden to hear case for Keystone XL
World shares retreat despite strong growth data from China
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
3 Grocery Store Stocks to Put in Your Cart
Greyscale Bitcoin Trust (OTCMKTS: GBTC) Stock is the Bitcoin Derivative of Choice
Opendoor Technologies (NASDAQ: OPEN) Stock is a Disruptive Housing Play
The Latest: Some Polish hospitals suspend vaccination
pixel
Carmaker Stellantis shares jump in Milan, Paris on first day
Alberta leader urges Biden to hear case for Keystone XL
World shares retreat despite strong growth data from China
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
3 Grocery Store Stocks to Put in Your Cart
Greyscale Bitcoin Trust (OTCMKTS: GBTC) Stock is the Bitcoin Derivative of Choice
Opendoor Technologies (NASDAQ: OPEN) Stock is a Disruptive Housing Play
The Latest: Some Polish hospitals suspend vaccination
pixel
Carmaker Stellantis shares jump in Milan, Paris on first day
Alberta leader urges Biden to hear case for Keystone XL
World shares retreat despite strong growth data from China
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
3 Grocery Store Stocks to Put in Your Cart
Greyscale Bitcoin Trust (OTCMKTS: GBTC) Stock is the Bitcoin Derivative of Choice
Opendoor Technologies (NASDAQ: OPEN) Stock is a Disruptive Housing Play
The Latest: Some Polish hospitals suspend vaccination
pixel
Carmaker Stellantis shares jump in Milan, Paris on first day
Alberta leader urges Biden to hear case for Keystone XL
World shares retreat despite strong growth data from China
pixel
Log in
ASX:PYC

PYC Therapeutics Limited (PYC.AX) Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
PYC Therapeutics Limited provides drug discovery services utilizing peptide libraries and proprietary screening capabilities in Australia. The company provides next generation delivery platform for cell-penetrating peptides (CPPs), a small biological molecule. The company's proprietary peptide libraries contain fragments from diverse and evolutionarily distinct microbial genomes - organisms which known as cell-penetrating properties. It develops CPP- Antisense Oligonucleotides (ASOs), a pipeline of drugs for the treatment of retinal disease. The company was formerly known as Phylogica Limited and changed its name to PYC Therapeutics Limited in November 2019. PYC Therapeutics Limited was incorporated in 2001 and is based in Nedlands, Australia.

MarketRank™

Overall MarketRank™

0.00 out of 5 stars

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Stock Exchange ASX
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
Current SymbolASX:PYC
Previous Symbol
CUSIPN/A
CIKN/A
Webpyctx.com
Phone61 8 6151 0992
EmployeesN/A

Debt

Debt-to-Equity Ratio2.64
Current Ratio36.23
Quick Ratio36.15

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$62,500.00
Price / Sales0.00
Cash FlowN/A
Price / Cash FlowN/A
Book ValueA$0.01 per share
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive PYC News and Ratings via Email

Sign-up to receive the latest news and ratings for PYC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











PYC Therapeutics Limited (PYC.AX) (ASX:PYC) Frequently Asked Questions

What stocks does MarketBeat like better than PYC Therapeutics Limited (PYC.AX)?

Wall Street analysts have given PYC Therapeutics Limited (PYC.AX) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but PYC Therapeutics Limited (PYC.AX) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of PYC Therapeutics Limited (PYC.AX)'s key competitors?

Some companies that are related to PYC Therapeutics Limited (PYC.AX) include (CHV) (CHV), (DDXS) (DDXS), (PREV) (PREV), (TNGN) (TNGN), 138267 (COM.TO) (COM), 17031 (MYM), Abattis Bioceuticals (ATTBF), Abzena plc (ABZA.L) (ABZA), Acrux Limited (ACR.AX) (ACR), Actinogen Medical Limited (ACW.AX) (ACW), AdAlta Limited (1AD.AX) (1AD), ADiTx Therapeutics (ADTX), Admedus (AHZ), Alaric (HALB) and Algernon Pharmaceuticals (AGNPF).
View all of PYC's competitors.

Who are PYC Therapeutics Limited (PYC.AX)'s key executives?

PYC Therapeutics Limited (PYC.AX)'s management team includes the following people:
  • Dr. Rohan Hockings MBBS, MBBS (Hons.), J.D., G.D.L.P, CEO & Director (Age 38, Pay $395k)
  • Mr. Kevin Hart B.Com., F.C.A., B.Com, FCA, Company Sec. & CFO (Age 59)
  • Prof. Sue Fletcher, Chief Scientific Officer
  • Mr. Sahm Nasseri M.B.A., MBA, CEO of US operations & Director (Age 37)
  • Mr. Kaggen Ausma L.L.B., Chief Bus. Officer
  • Dr. May Orfali, Chief Medical Officer of US Operations

What is PYC Therapeutics Limited (PYC.AX)'s stock symbol?

PYC Therapeutics Limited (PYC.AX) trades on the ASX under the ticker symbol "PYC."

How big of a company is PYC Therapeutics Limited (PYC.AX)?

PYC Therapeutics Limited (PYC.AX) has a market capitalization of $0.00 and generates $62,500.00 in revenue each year.

What is PYC Therapeutics Limited (PYC.AX)'s official website?

The official website for PYC Therapeutics Limited (PYC.AX) is pyctx.com.

How can I contact PYC Therapeutics Limited (PYC.AX)?

The company can be reached via phone at 61 8 6151 0992.

This page was last updated on 1/18/2021 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.